United Therapeutics Corp (NASDAQ:UTHR)

170.92
Delayed Data
As of May 01
 +11.23 / +7.03%
Today’s Change
84.63
Today|||52-Week Range
190.29
+31.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues289.4M322.8M330.0M346.4M
 
 
 
 
 
Cost of Goods Sold23.0M31.1M32.7M6.8M
 
 
 
 
 
Depreciation And Amortization7.6M7.6M8.1M8.9M
 
 
 
 
 
 
Operating ExpensesGross Income258.8M284.1M289.1M330.6M
 
 
 
 
 
General Expenses42.7M107.8M321.4M152.0M
 
 
 
 
 
Research And Development12.4M39.7M118.9M71.5M
 
 
 
 
 
Total Operating Expenses73.3M146.5M362.2M167.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income216.1M176.3M-32.2M178.6M
 
 
 
 
 
Extraordinary Credit0.001.1M0.000.00
 
 
Extraordinary Charge-17.00--0.00--
 
 
Interest Expense On Debt4.6M4.7M4.7M3.5M
 
 
 
 
 
Other Expenses454.0K-800.0K1.1M-285.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income213.2M173.0M-35.8M174.8M
 
 
 
 
 
Income Taxes-75.7M-61.2M-10.6M-58.8M
 
 
 
 
 
Net Income137.5M111.9M-25.2M115.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.4M47.6M47.3M47.4M
 
 
 
 
 
Shares To Calculate EPS Diluted56.7M53.3M47.3M53.5M
 
 
 
 
 
 
Earnings Per ShareEPS$2.43$2.10-$0.53$2.17
 
 
 
 
 
EPS Diluted$2.43$2.10-$0.53$2.17
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account